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Summary of key finding: We found ameliorating effects of Juzentaihoto on restraint 
stress- and P. gingivalis-induced alveolar bone loss in rats. 
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ABSTRACT   
Objective: Juzentaihoto (JTX) is a traditional Japanese medicine that consists of 10 
herbs. The purpose of this study was to evaluate the efficacy of multi-herbal medicine 
JTX as a preventive and therapeutic drug for periodontal bone resorption and for 
reducing restraint stress.  
Material and methods: Porphyromonas gingivalis ATCC 33277 was used for testing the 
antibacterial activity of JTX and a rat experimental periodontitis model. To evaluate the 
effect of JTX against P. gingivalis infection, we determined the differences in alveolar 
bone loss among experimental groups. The concentrations of adrenocorticotropic 
hormones were measured as stress markers, and atrophy of the thymus and spleen was 
assessed.  
Results: JTX had antibacterial activity against P. gingivalis ATCC 33277. JTX treatment 
of mouse bone marrow cells at a concentration of 0.1 μg/ml significantly inhibited 
osteoclast formation. Administration of JTX to rats with P. gingivalis infection and 
restraint stress significantly reduced alveolar bone loss compared with the case with just 
the combination of P. gingivalis infection and restraint stress. In the restrained groups, 
stress markers were elevated, and the thymus and spleen were atrophied. The groups 
with administration of JTX showed not only inhibition of the decrease of weight but 
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also normalization of corticosterone and cortisol values.  
Conclusion: JTX effectively inhibited restraint stress and osteoclastogenesis. It appears 
that the effects of JTX inhibit the destruction of periodontal tissue by suppressing stress. 
Our study demonstrated that JTX affects the correlation between restraint stress and 
periodontitis.  
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1. INTRODUCTION 
Dental plaque is a bioﬁlm consisting of multiple species of oral bacteria and their 
metabolic products. Periodontitis is a chronic inflammatory disease of the supporting 
tissues of the teeth associated with the emergence of a consortium of Gram-negative 
bacteria in subgingival plaque.1 P. gingivalis has received considerable attention 
because it can represent up to 50% of anaerobically cultivable bacteria from adult 
periodontal lesions.2 An increase in the severity of periodontitis was also associated 
with an increase in the subgingival level of P. gingivalis, and resolution of the disease 
was associated with a reduction in the level of the bacterium.3,4 Furthermore, 
subgingival implantation of P. gingivalis in mice, rats and non-human primates 
reportedly induced periodontal bone loss.5,6 These studies in humans and animals 
implicated P. gingivalis as a major causative agent in the development of periodontitis.  
P. gingivalis possesses a number of virulence factors that enable it to colonize the oral 
cavity and to destroy gingival tissues, such as fimbriae, strong proteolytic activity, 
lipopolysaccharides, vesicles and outer membrane proteins.7 Besides these direct 
host–pathogen interactions, periodontitis is exacerbated by risk factors including age, 
male gender, smoking and diabetes mellitus.8  
Psychological factors have also been suspected of increasing the risk of periodontitis.9 
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The stress response is thought to be a mediating mechanism between unfavorable 
psychological conditions and inflammatory periodontal disease. Some studies have 
reported a higher prevalence of chronic destructive periodontal disease in individuals 
with psychological stress, which may be associated with acute necrotizing periodontal 
disease.10-15 Concerning the mechanism linking stressful conditions and periodontal 
diseases, there are many reports describing that psychological stress can downregulate 
the cellular immune response. 16-20 
Kampo medicine is traditional Japanese herbal medicine that also uses substances that 
are of pharmaceutical grade; it is integrated into the national medical system. The 
principles of Kampo are based on old Chinese traditional medicines and about one 
hundred and fifty kinds of compositions of natural herbs and other natural products. 
Juzentaihoto (JTX; Shi-Quan-Da-Bu-Tang in Chinese) is a Kampo medicine that 
consists of 10 herbs: Ginseng radix, Astragali radix, Angelicae radix, Rehmanniae 
radix, Atractylodis lanceae rhizoma, Cinnamomi cortex, Poria, Paeoniae radix, 
Ligustici rhizoma and Glycyrrhizae radix. It has been traditionally used for centuries for 
general malaise. Currently, JTX is widely prescribed for anemia, rheumatoid arthritis, 
chronic fatigue syndrome and inflammatory bowel diseases. It is also widely used for 
the prevention of cancer metastasis and infection in immunocompromised patients.21 
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There are various methods of treating periodontal conditions, such as using tetracycline 
antibiotics and anti-inflammatory agents. Ideal antibacterial substances must be 
effective against numerous microorganisms, act rapidly, maintain activity at low 
concentrations, have no side effects and be usable without causing discomfort. 
Frequently used antibacterial chemicals include povidone iodine, chlorhexidine and 
cetylpyridinium chloride; in addition, natural antibacterial substances have attracted 
attention. 22-24  
In the medical field, combinations of Japanese traditional herbal medicine and Western 
medicine are applied. However, Japanese traditional medicine has rarely been applied in 
dentistry. In the present study, we investigate the antibacterial effect of JTX and the 
inhibitory effect of JTX on the differentiation of mouse bone marrow cells into 
osteoclasts. Furthermore, we used a rat periodontitis model to determine the inhibitory 
efficacy of JTX on the combination of restraint stress and P. gingivalis-induced alveolar 
bone loss. 
 
 
2. Materials and methods 
2.1. Bacterial strain and growth conditions 
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The bacterial strain used in this study was P. gingivalis American Type Culture 
Collection (ATCC) 33277. It was grown at 37ºC for 18 h in an anaerobic chamber with 
an atmosphere of 85% N2, 10% H2 and 5% CO2 in brain heart infusion broth (BHI 
broth; Becton Dickinson and Company, Sparks, MD, USA) supplemented with 5 mg/ml 
yeast extract, 5 μg/ml hemin and 0.2 µg/ml menadione. 
 
2.2. Preparation of herbal medicine 
Juzentaihoto (JTX) used in this study was obtained from Tsumura & Co., Ltd. (Tokyo). 
JTX powder was dissolved in phosphate-buffered saline (PBS; pH 7.4) and serially 
diluted (100 mg/ml, 10 mg/ml and 1 mg/ml) with PBS for use in evaluating the 
antibacterial activity against P. gingivalis. Ten mg/ml JTX was prepared in distilled 
water for evaluating the inhibitory efficacy of the Kampo medicine on experimental 
periodontitis in rats. To examine cell viability and osteoclast differentiation, JTX was 
prepared in α-minimum essential medium (α-MEM; GIBCO, Grand Island, NY, USA) 
and serially diluted from 100 μg/ml to 0.01 μg/ml. 
 
2.3. Antibacterial activity against P. gingivalis 
Exponentially growing P. gingivalis cells were washed and suspended in PBS to an 
8 
 
optical density of 1.0 at 600 nm. Ten μl of the bacterial suspension was exposed for 5, 
15 and 60 minutes to 1 ml of the 100 mg/ml, 10 mg/ml and 1 mg/ml JTX, or the same 
volume of PBS as a control. At the end of the incubation period, 10-fold serial dilution 
was carried out in PBS and 100 μl of each dilution was spread onto a BHI blood agar 
plate. The number of CFU (colony forming units) was determined after 7 days of 
incubation in an anaerobic atmosphere. Each experiment was performed three times and 
the mean values of the experiments are shown. 
 
2.4. Cell viability assay 
A cell viability assay was performed to examine the effect of JTX on the cytotoxicity of 
MC3T3-G2/PA6 cells (RIKEN Cell Bank, Tsukuba, Japan), pre-adipocytes similar to 
bone marrow-derived stromal cells, using a CellTiter 96® Aqueous Non-Radioactive 
Cell Proliferation Assay kit, which consisted of a novel tetrazolium compound (MTS) 
and an electron-coupling reagent (Promega Co., Madison, WI, USA). MC3T3-G2/PA6 
cells were placed in 96-well plates at a concentration of 1 x 104 cells/well and were 
grown in α-MEM containing 20% fetal bovine serum (FBS; SAFC Biosciences, Denver, 
KS, USA) to sub-confluence. The cells were then treated with 100 μg/ml, 10 μg/ml, 1 
μg/ml, 0.1 μg/ml and 0.01 μg/ml JTX for an additional 2 days. Subsequently, 20 μl of 
9 
 
MTS solution was added to each well and the cells were incubated for 4 h at 37°C. After 
incubation, the optical density of the formazan solution was measured at 490 nm. The 
results are expressed as the mean ± standard deviation (SD) of the relative percentage of 
viability compared with that of negative controls without JTX (n = 5). 
 
2.5. Osteoclast differentiation assay 
Bone marrow cells (1.5 x 105 cells/well), obtained from the tibiae of 5- to 8-week-old 
BALB/c mice, and MC3T3-G2/PA6 cells (1.5 x 104 cells/well) were co-cultured for 7 
days in the presence of 10-8 M 1α,25-(OH)2D3 (Calcitriol; Wako Pure Chemical 
Industries, Osaka, Japan) and 10-8 M dexamethasone (Sigma-Aldrich, St. Louis, MO, 
USA) in α-MEM supplemented with 20% FBS in 48-well plates under a 5% CO2 
atmosphere. To determine the inhibitory effects of JTX on osteoclast formation, JTX 
was added to the culture at final concentrations of 10 μg/ml, 1 μg/ml, 0.1 μg/ml and 
0.01 μg/ml and cultured for 7 days. After 7 days, the co-cultured cells were stained for 
tartrate-resistant acid phosphatase (TRAP), a marker enzyme of osteoclasts. 
TRAP-positive multinucleated cells containing three of more nuclei were counted as 
osteoclasts. The results are expressed as the means ± SD of triplicate cultures. 
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2.6. Animals 
Forty-eight male, specific-pathogen-free (SPF), 4-week-old, Sprague-Dawley rats, each 
weighing 50–60 g, were used in the experiments. The rats were obtained from a 
commercial farm (Nihon SLC, Shizuoka, Japan) and housed in cages throughout the 
experimental period to facilitate successful isolation. The rats were fed a standardized 
diet of hard briquettes and water, and were maintained under a 12-h light-dark cycle 
(lights on 08:00–20:00) at a temperature of 22ºC and relative humidity of 50%.  
 
2.7. Experimental procedure 
The body weight of the rats was recorded every 2 days in the morning from the 
beginning to the end of the experimental period. The rats were given sulfamethoxazole 
(1 mg/ml) and trimethoprim (200 μg/ml) in drinking water for 4 days to reduce the 
original oral flora, followed by a 4-day antibiotic-free period before being challenged 
with P. gingivalis. The rats were orally infected with P. gingivalis ATCC 33277, which 
was suspended in 5% carboxymethylcellulose, and each rat received 0.5 ml (1.5 x 1010 
cells/ml) by oral gavage three times at 48-h intervals. Restraint stress was induced by 
enclosing each animal in flexible wire mesh (5 × 5 mm) shaped to fit its body from 
20:00 to 8:00 (12 h) for the experimental period. To examine the efficacy of JTX for 
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periodontal bone resorption and for reducing restraint stress, a 10 mg/ml solution was 
used for their drinking water. The estimated dose levels in rats were calculated to match 
the typical estimated human exposure. The six rats in each cage belonged to the same 
group.  
The rats were randomly divided into the following eight groups of six rats each: group 
A, serving as P. gingivalis-uninfected control (sham); group B, administered JTX; group 
C, infected with P. gingivalis; group D, infected with P. gingivalis and administered 
JTX; group E, exposed to restraint stress; group F, exposed to restraint stress and 
administered JTX; group G, exposed to restraint stress and infected with P. gingivalis; 
and group H, exposed to restraint stress, infected with P. gingivalis and administered 
JTX (Fig. 1). In the unrestrained groups (groups A through D), the rats were denied food 
and water for the same time period, but were not restrained  (Fig. 1). 
The experimental procedures of this study were reviewed and approved by the 
Committee of Ethics on Animal Experiments of Kanagawa Dental University and were 
carried out under the guidelines for animal experimentation of Kanagawa Dental 
University, which are in accordance with the NIH Guide for the Care and Use of 
Laboratory Animals. 
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2.8. Measurement of alveolar bone loss 
One aspect of periodontal disease is the resorption of alveolar bone. The upper jaws 
were defleshed after 10 min in an autoclave at 15 pounds/inch2, and were then 
immersed in 3% hydrogen peroxide, rinsed, air-dried and stained with 1% methylene 
blue. Horizontal alveolar bone resorption around the maxillary molars was evaluated 
morphometrically. The distance between the cemento-enamel junction (CEJ) and the 
alveolar bone crest (ABC) was measured at seven buccal sites per rat.25 Measurements 
were made under a dissecting microscope (x 40) fitted with a digital high-definition 
system (digital HD microscope VH-7000; Keyence, Osaka, Japan) that was 
standardized to provide measurements in millimeters. 
 
2.9. Measurement of corticosterone and cortisol 
In order to clarify the ameliorative effect of JTX on restraint stress in the rats, blood was 
taken by cardiac puncture under anesthesia (Veterinary Ketalar® 50, Sankyo Co., Ltd., 
Tokyo, Japan) to measure the corticosterone and cortisol when the animals were 
sacrificed. Blood samples were centrifuged, separated into serum and kept frozen at 
-20ºC. In the case of corticosterone and cortisol, serum was assayed using a commercial 
radioimmunoassay kit (Immunotech, Beckman Coulter Co., Fullerton, CA, USA). 
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2.10. Statistical analysis 
Differences among experimental groups were analyzed with Fisher’s protected least 
significant difference (PLSD) by one-way analysis of variance. The 5% level of 
significance was selected for rejecting hypotheses. Computations were performed using 
a statistical software program (STATVIEW version 5.0; Abacus Concepts, Inc., 
Berkeley, CA, USA).  
 
 
3. RESULTS 
3.1. Antibacterial activity against P. gingivalis 
The treatment of P. gingivalis with 100 mg/ml, 10 mg/ml and 1 mg/ml JTX reduced the 
number of viable cells. At concentrations of 100 mg/ml and 10 mg/ml JTX, antibacterial 
activity against P. gingivalis was observed for the 60 min treatment and the numbers of 
CFU of P. gingivalis decreased from 4.12 ± 0.05 x 107 to zero per milliliter and 1.93 ± 
0.10 x 104 per milliliter, respectively (Fig. 2). 
 
3.2. Effect of JTX on cell viability 
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The MTS assay was performed to assess the effect of JTX on MC3T3-G2/PA6 cell 
viability and to determine the appropriate concentration for treating cell cultures. 
Compared with untreated cells, JTX concentrations up to 10 μg/ml showed no 
significant effect on cell viability. Therefore, JTX was used at concentrations of 10 
μg/ml, 1 μg/ml, 0.1 μg/ml and 0.01 μg/ml in the osteoclast formation.  
 
3.3. JTX inhibits osteoclast differentiation 
TRAP-positive multinucleated osteoclasts were formed in the co-cultures of 
MC3T3-G2/PA6 cells and mouse bone marrow cells in the presence of 1α,25-(OH)2D3 
and dexamethasone. Treatment with JTX (at concentrations of 10 μg/ml, 1 μg/ml and 
0.1 μg/ml) significantly inhibited osteoclast formation (**p < 0.01, *p < 0.05, Fig. 3). 
However, no inhibitory effect was observed in co-culture cells with 0.01 μg/ml JTX. 
 
3.4. Alveolar bone loss 
To evaluate the effect of JTX against restraint stress- and P. gingivalis-induced alveolar 
bone loss, bone level differences of the rats were determined. Morphometric bone levels 
were shown in Fig. 4A. The mean [± standard error of the mean (SEM)] CEJ-ABC 
distance at each of the seven measurement sites was compared among groups (Fig. 4B). 
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As alveolar bone decreased, the CEJ-ABC distance increased in the eight experimental 
groups. The bone levels of groups A, B, C and D were 0.19 ± 0.04 mm, 0.20 ± 0.02 mm, 
0.37 ± 0.01 mm and 0.24 ± 0.02 mm, respectively. The level of bone loss in group C, 
which was infected with P. gingivalis, was significantly greater than that in group A (p < 
0.05), indicating that P. gingivalis infection was associated with bone loss. The bone 
loss level of the group administered JTX with P. gingivalis infection was remarkably 
less than that of the P. gingivalis infection group (p < 0.05), whereas administration of 
JTX itself had no effect on alveolar bone resorption. The bone loss level of group G 
with combined restraint stress and P. gingivalis infection was 0.43 ± 0.05 mm, which 
was 2.24-fold higher than that of the control without P. gingivalis infection (group A) (p 
< 0.01). Although no significant difference of bone loss level was observed between 
control group A and stress group E, the combination of restraint stress and P. gingivalis 
infection (group G) exacerbated the alveolar bone resorption in comparison to that with 
P. gingivalis infection alone (group C) (p < 0.05). The administration of JTX to cases of 
P. gingivalis infection with restraint stress (group H) significantly reduced the bone 
resorption (p < 0.05). Since the bone level of group H was comparable to that of group 
D, without restraint stress, administration of JTX may alleviate the exacerbating effect 
of restraint stress on alveolar bone resorption induced by P. gingivalis. 
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3.5. The weights of body, thymus and spleen 
At the beginning of the experimental period, all rats had similar body weights. Because 
the rats were in their growth period, their body weights increased during the experiment. 
In the restrained groups (groups E through H), overall lower increases in body weights 
were observed compared with those in the unrestrained groups (groups A through D). In 
particular, in restraint stress group E and combined restraint stress and P. gingivalis 
infection group G, the body weights were significantly lower than those in control 
group A and P. gingivalis infection group C (p < 0.01 and p < 0.05), respectively, at the 
end of the experimental period (Table 1). Interestingly, the administration of JTX 
(groups F and H) inhibited the decrease of body weight under the restrained condition 
and the body weights of the rats were similar to those in control group A. The mean 
body weight in group B, in which the rats were administered JTX, was higher than that 
in control group A. The weights of thymus and spleen were measured on day 30. No 
significant differences were observed in thymus and spleen weights among unrestrained 
groups (groups A through D). However, thymus and spleen weights were significantly 
lower in restraint stress groups E and G than in unrestrained groups A and C, 
respectively (p < 0.01 and p < 0.05), indicating that the stress caused remarkable 
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atrophy of the thymus and spleen. On the other hand, the weights of the thymus and 
spleen in the groups administered JTX under the restraint stress condition (groups F and 
H) were similar to those in groups B and D, respectively.  
 
3.6. Systemic biomarkers of stress 
Blood cortisol and corticosterone levels are shown in Table 2. In the restrained group 
(group E), corticosterone and cortisol values were significantly higher than those in the 
control (group A) (p < 0.05). On the other hand, the administration of JTX significantly 
decreased the corticosterone and cortisol levels in group F, which was exposed to 
restraint stress and administered JTX, compared with those in restraint stress group E (p 
< 0.01). Both hormone levels in group F were comparable to those in control group A. 
 
 
4. DISCUSSION 
Periodontal diseases are infectious and induce inflammation in the supportive tissues of 
teeth in response to the accumulation of pathogens in the subgingival crevice. The rat 
experimental periodontitis model used in this study is a relatively simple in vivo model 
in which a single periodontal organism infects the animal, leading to destructive 
18 
 
periodontitis.  
Kampo medicines have been suggested to have antibiotic or prebiotic effects.26 Some 
constituent herbs of JTX and its ingredients have been reported to have antimicrobial 
effects.27,28 Especially, the compounds of Glycyrrhizae radix were complete growth 
inhibition of P. gingivalis.29 Therefore, Glycyrrhizae radix may play an important role in 
the bactericidal effect of JTX against P. gingivalis. The antibacterial activity against P. 
gingivalis may be explained by the synergism between the constituents in the herbal 
composites. In this study, the antibacterial activity against P. gingivalis was observed 
with 100 mg/ml and 10 mg/ml of JTX treatment. The treatment of P. gingivalis with 
JTX reduced the number of viable cells in a time- and concentration-dependent manner. 
Thus, JTX may exhibit potential combinatory effects of its herbs on P. 
gingivalis-induced alveolar bone loss in rats. JTX may inhibit the adherence and 
colonization of P. gingivalis in rat oral cavity. Moreover, 0.1 μg/ml JTX significantly 
inhibited osteoclast formation (Fig. 3). Angelicae gigantis radix had significantly 
decreased both TNF-alpha-induced TRAP positive cells and TRAP activity.30 
Furthermore, JTX includes immmunomodulating substances. Glycyrrhizin extracted 
from Glycyrrhizae radix and the extracts of Astragali radix have anti-inflammatory.31,32 
In addition, the extracts from Ginseng radix, Cinnamomi cortex, Glycyrrhizae radix, 
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Astragali radix and Paeoniae radix have antioxidative activities.33-37  
Alveolar bone resorption was greater in the infection with P. gingivalis group (group C) 
than in the sham group (group A). Administration of JTX along with P. gingivalis 
infection group (group D) significantly reduced alveolar bone loss (Fig. 4).  
A number of herbal formulas of traditional Japanese medicines are characterized by the 
use of mixtures of several herbs in a single formula. It has been postulated that, in 
multiherbal formulas, the pharmacological activity of one single herb is either 
potentiated or prolonged, and/or its adverse effects reduced, due to synergistic or 
antagonistic effects, by the addition of other herbs. A component of JTX suppressed 
osteoclast differentiation from bone marrow macrophages treated with receptor 
activator of nuclear factor kappa-B ligand (RANKL) without any cytotoxicity. This 
component also significantly reduced RANKL-induced expression of transcription 
factors, c-Fos and nuclear factor of activated T-cells, as well as the osteoclast marker 
TRAP.38,39 Since no significant inhibitory effect on cell viability of MC3T3-G2/PA6 
cells was observed with JTX, the same suppression of signal transduction may result in 
a decrease of signal transduction and a decrease of the level of osteoclast formation. 
One study reported that JTX caused the induction of interleukin (IL)-12 and subsequent 
activation of natural killer T (NKT) lymphoid cells.40 Other work has mentioned IL-18 
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induction as a possible result of JTX. These cells have a role in both innate and adaptive 
immune responses.41 Cytokines, such as IL-12 and IL-18, are also important activators 
of NKT cells.42 Yamada et al.43 investigated the in vitro effect of IL-18 on osteoclastic 
bone-resorbing activity, and found that when IL-18 was applied to osteoclast-enriched 
cell cultures, bone-resorbing activity decreased.  
Psychological factors have been suspected of increasing the risk of periodontitis.9 Genco 
et al.16 reported that analyses of the role of stress in infectious processes, such as 
periodontal disease, should consider the overall effects of stressors appraised by the 
brain. Breivik et al.44 demonstrated that periodontal disease susceptibility and 
progression could be explained, at least in part, by brain neuroendocrine-immune 
regulatory mechanisms. Genetically determined hypothalamo-pituitary-adrenal (HPA) 
axis reactivity also appears to play an important role, and periodontal disease is likely to 
send feedback signals to the brain.45  
Thymus and spleen weights in the restrained group decreased 28% and 29% compared 
with those in the control, respectively. However, the thymus and spleen weights of the 
group with restraint stress and JTX administration recovered to 103% and 100% of 
those of the control, respectively. These results indicate the physiological burden caused 
by restraint stress in rats and that JTX relieved this stress (Table 1). The blood 
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glucocorticoid levels were measured as markers of stress adaptation. In the restrained 
group, the levels of the hormone markers cortisol and corticosterone were elevated with 
involution of the thymus and spleen (Table 2). Our results showed that the 
administration of JTX could ameliorate the alveolar bone loss induced by restraint stress, 
possibly by preventing reductions of high glucocorticoid response. As shown in Table 2, 
corticosterone and cortisol values were decreased by JTX administration.  
The combination of restraint stress and P. gingivalis infection (Fig. 4, group G) resulted 
in significantly higher attachment and alveolar bone loss than in P. gingivalis infection 
alone. The administration of JTX along with the combination of restraint stress and P. 
gingivalis infection decreased the alveolar bone resorption (Fig. 4, group H). However, 
restraint stress alone did not induce alveolar bone loss (Fig. 4, group E). 
In the combined restraint stress and P. gingivalis infection group, it was suggested that 
there may be some compensation for the reduction in the lymphatic organ size 
following stress, and that the immune system of restrained rats was weaker, thereby 
promoting alveolar bone loss. The present study showed that administration of JTX 
decreased the induction of stress markers, and resulted in lower attachment and alveolar 
bone loss than in restraint stress with P. gingivalis infection. These results indicate that 
JTX may prevents the physiological burden caused by restraint stress in rats. With 
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regard to glucocorticoid regulation, Ginseng radix may be involved in its beneficial 
action. Saponins of Ginseng radix, a component of JTX, similarly increased adrenal 
cAMP, a secondary messenger of adrenocorticotropic hormone, and thereby stimulated 
the synthesis and secretion of corticosteroids in normal but not hypophysectomized 
rats.46 Ginseng saponins also acted as a functional ligand for glucocorticoid receptors.47 
Since glucocorticoids are considered to be essential hormones for overcoming acute 
physical stress, these ingredients may facilitate the resistance, coping and adaptation 
responses of organisms to stress through modulation of the glucocorticoid secretion 
system. These actions may be involved in the anti-stress effect of JTX.  
Kato et al.48 reported that the intestinal microflora affects the impact of the multi-herbal 
product JTX on gene expression in the gut and liver. The administration of JTX changes 
the intestinal microflora and, as a result, changes the expression levels of HSP105 and 
HSP70 in the liver and intestine. The expression levels of HSPs in these organs may 
correspond to the level of inflammation produced in the intestinal tract and JTX plays a 
role to reduce the inflammation. We showed that JTX has two functions that effectively 
inhibited restraint stress and osteoclastogenesis in this study. It appears that the effects 
of JTX inhibit the destruction of periodontal tissue by suppressing stress. JTX appears 
to inhibit the progression of periodontal disease as well as to reduce stress. 
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In conclusion, the present results suggest that JTX ameliorates stress and inhibits the 
progression of periodontal disease by suppressing the maturation of osteoclasts. In 
addition, these findings suggest that restraint stress may play a role in periodontal 
disease. The obtained findings may lead to the use of JTX as a therapeutic drug in 
dental care, such as for periodontitis. However, further research is required to clarify the 
effective ingredients in JTX and to discover the mechanism underlying its action. 
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FIGURE LEGENDS 
Fig. 1 - Experimental design. The rats were divided into eight groups (n = 6/group): 
group A, control (not infected with P. gingivalis); group B, administered JTX; group C, 
infected with P. gingivalis; group D, infected with P. gingivalis and administered JTX; 
group E, exposed to restraint stress; group F, exposed to restraint stress and then 
administered JTX; group G, exposed to restraint stress and infected with P. gingivalis; 
and group H, exposed to restraint stress, infected with P. gingivalis and administered 
JTX. 
 
Fig. 2 - Antibacterial effect of JTX on P. gingivalis. Bacterial cells were treated with 
100 mg/ml (▲), 10 mg/ml () or 1 mg/ml (●) JTX or PBS (○) for the indicated period. 
 
Fig. 3 - JTX inhibits osteoclast differentiation of BALB/c mouse bone marrow cells 
co-cultured with MC3T3-G2/PA6 cells. After incubation for 7 days, co-cultured cells 
were stained for TRAP (A), and TRAP-positive multinucleated cells containing three or 
more nuclei were counted as osteoclasts (B). Results are expressed as the mean ± SD of 
triplicate cultures. **p < 0.01, *p < 0.05. 
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Fig. 4 - Morphometric bone levels. The skulls of the rats were defleshed and stained 
with 1% methylene blue. The skeletal specimens were as follows: group A, control; 
group B, administered JTX in drinking water; group C, infected with P. gingivalis; 
group D, infected with P. gingivalis and administered JTX; group E, exposed to restraint 
stress; group F, exposed to restraint stress and administered JTX; group G, exposed to 
restraint stress and infected with P. gingivalis; and group H, exposed to restraint stress, 
infected with P. gingivalis and administered JTX (A). Measurement of bone levels was 
performed by comparing the distance from the cemento–enamel junction (CEJ) to the 
alveolar bone crest (ABC) at seven palatal sites on three molars on the left side of the 
maxilla. Values indicate mean bone loss levels ± standard error of the mean (n = 
6/group) (B). **p < 0.01,*p< 0.05. 
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